Purple Biotech Ltd. (PPBT) Tops Q2 EPS by 1c

Purple Biotech Ltd. (NASDAQ: PPBT) reported Q2 EPS of ($0.25), $0.01 better than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Purple Biotech Ltd. (PPBT) click here.

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Barclays Starts Bitdeer Technologies Group (BTDR) at Overweight
• Analog Devices climbs as fiscal Q3 results, Q4 outlook beat forecasts